Arthritis & Rheumatology

Article	Citations
No differences in myocardial perfusion between treatment‐naive, early rheumatoid arthritis patients and healthy controls	454
	228
Higher alcohol consumption was associated with greater incidence of total hip replacement due to hip osteoarthritis in a dose‐dependent manner in women: comment on the article by Marchand et al	195
The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era	177
	175
Clinical Connections	148
Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al	139
Clinical Connections	119
Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et al.	117
Seronegative palindromic rheumatism: what are we talking about? Comment on the article by Yang et al	109
Clinical Images: Rice bodies in pseudogout	106
In This Issue	96
The Devil Is in the Detail: Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty	92
Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis	82
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial	81
Reply	80
Clinical Connections	76
The Impact of Nonsteroidal Anti‐Inflammatory Drugs on Radiographic Spinal Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From an Inception Cohort	75
Minimal tofacitinib dose for maintenance in axial spondyloarthritis: real‐world data from a resource‐limited setting	74
Correction to “Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort”	72
A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis	70
A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody–related vasculitis criteria sets: comment on criteria sets approved by the American College of	70
Reply	70
TWIST1 ‐Mediated Induction of AEBP1 in Fibroblast‐Like Synoviocytes Activates Transforming Growth Factor β Signaling t	67
In This Issue	67

Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy	64
National Mortality Databases to Assess Disease Burden in Systemic Autoimmune Diseases: A Valuable Resource But With Limitations	64
Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis	62
NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2‐Mediated Pyroptosis Through the Phosphorylated Salt‐Inducible Kinase 1/Sterol Regulatory Element Binding T	62
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis	61
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis	59
Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General‐Population Cohort Analysis With Extended Quantile g‐Computation	58
CCL19‐Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase	57
Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis	56
Interleukin‐13 Receptor α1–Mediated Signaling Regulates Age‐Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis	55
Homocitrullinated Peptides Drive Pro‐Inflammatory T Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis	55
Using Mice to Model Human Osteoarthritis: Age, Biologic Sex, and Pain Matter	54
Distinct Natural Killer Cell Signature in Still Disease: Insights From a Multinational Immunome Project Consortium for Autoinflammatory Disorders	54
Knee Alignment Correction by High Tibial Osteotomy Reduces Symptoms and Synovial Inflammation in Knee Osteoarthritis Accompanied by Macrophage Phenotypic Change From M1 to M2	54
Non‐melanoma skin cancer risk with Janus kinase inhibitors compared to interleukin‐6 receptor inhibitors in rheumatoid arthritis: results from a national cohort study	53
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of Osteoarthritis	53
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Tr	52
Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthr	52
In Synergy With Interferon‐γ, Interleukin‐17 Activates Vascular Stromal Cells Toward a Proinflammatory Profile in Giant Cell Arteritis	51
At the Heart of Treating Kawasaki Disease: The Search for New Approaches to Prevent Coronary Artery Aneurysms	51
Diagnostic Value and Treatment Responsiveness of Ultrasonography Features in Correlation With Clinical Findings in Early Peripheral Spondyloarthritis	51
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide	50
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades Using the Lupus Midwest Network	50
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis	49
Single‐Cell Analysis Reveals Peripheral Helper T Cells in Rheumatoid Arthritis–Related Interstitial Lung Disease	48
Successful Spontaneous Pregnancies and Healthy Neonates After Dual‐Target CAR –T Cell Therapy in Systemic Lupus Erythematosus	48
Exposure to Occupational Inhalants and the Risk of Developing Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis	48
Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immu	47
Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention	46
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases	46
Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans	45
Target trial emulation and cardiovascular safety inference in gout: comment on the article by Yokose et al.	45
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria	45
Revisiting the Ethics of Urate‐Lowering Therapy Clinical Trials for Gout Management	45
Reply	44
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation: An Early Remission Induction Study	43
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis–Associated Lymphoproliferative Disorders	43
Using Two Predictive Models to Capture Two Types of Poor Outcomes in Knee Arthroplasty: A Multisite Longitudinal Cohort Study	43
Reply	42
	42
Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis	42
In This Issue	42
Clinical Image: Nasal rim sign: A clinical manifestation of dermatomyositis	41
	41
Clinical Connections	41
Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits	41
Issue Information	40
Reply	40
Immediate Open Access: The Good, the Bad, and the Impact on Academic Society Publishing	40
Journal Club	40

Journal Club	40
Role of autoantibodies in lupus nephritis: comment on the article by Fava et al	39
Reply	38
	38
Revisiting the Synovium as a Structural Correlate of Pain in Osteoarthritis	38
Reply	37
Not Only Excruciating Pain: Might a Gout Flare Episode Lead to Pulmonary Embolism?	37
Clinical Images: A painful bipartite patella	37
The 2024 Vasculitis Foundation Quality Care Summit: Seeking Strategies to Improve Care for All Patients	36
Identification of Novel Noncoding Genetic Variants of Serum Urate Using Whole‐Genome Sequencing in 7,339 Chinese Participants	36
Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis	36
Reply	36
First‐Year IgG Dynamics in IgG4 ‐Related Disease: A Critical Window for Predicting Long‐Term Outco	35
Abstract Supplement ACR Convergence 2025	35
Effects of Secukinumab on Enthesiophyte and Erosion Progression in Psoriatic Arthritis: A One‐Year Double‐Blind, Randomized, Placebo‐Controlled Trial Using High‐Resolution Peripheral Quantitative Comp	35
	35
Development and External Validation of a Model Predicting New‐Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis	35
Oxidative Stress by the Mitochondrial Monoamine Oxidase B Mediates Calcium Pyrophosphate Crystal–Induced Arthritis	35
Cytokine‐induced NRP2 expression in rheumatoid arthritis fibroblast‐like synoviocytes: comment on the article by Jin et al	34
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb<	34
TOGETHER ‐ PsA and the case for precision phenotyping in psoriatic arthritis: comment on the article by Merola et al	34
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib	33
Lysosome‐Associated Membrane Protein 3 Induces Lysosome‐Dependent Cell Death by Impairing Autophagic Caspase 8 Degradation in the Salivary Glands of Individuals With Sjögren's Di	33
Variability of Primary Sjögren's Syndrome Is Driven by Interferon‐α and Interferon‐α Blood Levels Are Associated With the Class II HLA–DQ Locus	33
Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin‐Associated Periodic Syndrome	33
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome	32
Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Trial	32
Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion	32
Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis	32
EAT ‐Lancet Diet Modifies the Risk of Rheumatoid Arthritis Through Metabolomic Signature	32
Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling	32
Trends in New Use of Disease‐Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022	32
DNA Methylation Profiling Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Patterns Associated With Sex and Disease Activity in Childhood‐Onset Lupus	31
Journal Club	31
	30
Clinical Images: Increased bone metabolism in secondary hyperparathyroidism	30
Reply	30
In This Issue	30
An investigation of the relationship between weight management and gout: insights from the THIN database study and recommendations for improvement. Comment on the article by Wei et al	30
Reply	30
Reply	29
Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al	29
Clinical Images: Burton line and scar hyperpigmentation in a patient with severe lead poisoning and saturnine gout	29
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel	29
The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis: comment on the article by Yuan et al	29
Doctor versus artificial intelligence: patient and physician evaluation of large language model responses to rheumatology patient questions: comment on the article by Ye et al	29
In This Issue	29
Reply	29
Reply	29
Clinical Connections	28
Clinical Image: Esophageal dilation and stenosis in systemic sclerosis	28
Global burden of osteoarthritis attributable to high body mass index, 1990 to 2021: insights from the Global Burden of Disease study 2021: comment on the article by Lu et al	28
Clinical Images: Transient perivascular inflammation of the carotid artery syndrome	28
In This Issue	28
From Genome‐Wide Association Study Signal to Mechanism in Rheumatoid Arthritis: Lessons From a Single Risk Locus	28
Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus	28
Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic‐Refractory Lyme Arthritis	28
18F ‐Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment Within a Randomized Controlled Trial in Giant Cell Arteritis	28
ZBTB20 Regulating Postnatal Articular Cartilage Development and Homeostasis: Implications for Early‐Onset Osteoarthritis	28
Corrigendum	27
Clinical Images: Biopsy‐proven hydroxychloroquine‐induced cardiomyopathy in an adolescent with systemic lupus erythematosus	27
Skin Transcriptomics Reveal Shared Molecular Mechanisms for Skin and Lung Involvement in Systemic Sclerosis	27
Nationwide Trends in Medication Use and Adverse Outcomes in Lupus Pregnancies: Progress and Persistent Gaps	27
Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups	27
Potential Confounding by Weight Loss: Comment on the article by Jorge et al.	27
Higher Complement C4 Gene Copy Number Constitutes a Shared Genetic Risk Factor for Giant Cell Arte	27
Clinical images: VEXAS syndrome presenting as treatment‐refractory polyarteritis nodosa	27
Issue Information ‐ General Info	27
T cells, the Next Big Target in Axial Spondyloarthritis?	27
Screening of Environmental Chemicals to Characterize Exposures in Participants With Systemic Lupus Erythematosus	27
EULAR /American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis	26
A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis	26
A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis	26
The Efficacy of Short‐Term Bridging Strategies With High‐ and Low‐Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double‐Blin	26
Mucosal‐Associated Invariant T Cells in Rheumatic Diseases	26
Artificial Intelligence and Deep Learning for Rheumatologists	26
Role of Human Mesenchymal Stem Cells and Derived Extracellular Vesicles in Reducing Sensory Neuron Hyperexcitability and Pain Behaviors in Murine Osteoarthritis	26
Single‐Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus	26
Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis	26
Effect of Time to Start of Biologic Therapy on Treatment Response in Childhood Arthritis: Results From the UCAN CAN ‐ DU	25

Clinical images: Huriez syndrome, a rare scleroderma mimic	25
List of Reviewers	25
A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease	25
Reply	25
Retraction	25
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus	25
Circulating interferon alpha protein measured with digital enzyme‐linked immunosorbent assay as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the art	25
Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al	25
Erratum	24
Should lipoprotein(a) be routinely measured after COVID‐19? Comment on the article by Stahl et al	24
Journal Club	24
Reply	24
	24
Strength Training is Associated With Less Knee Osteoarthritis: Data From the Osteoarthritis Initiative: Comment on the Article by Lo et al	24
Clinical Connections	24
Autoantigen Peptide‐8‐Arm Polyethylene Glycol‐Dyes Specifically Recognize Antigen‐Specific B Cells and Improve the Diagnosis of Rheumatoid Arthritis	23
Challenges to Research Integrity in Rheumatology: The Threat of Paper Mills, Fraud, and Click Data Science	23
Transforming Rheumatology Practice With Technology: Products, Processes, People, and Purpose	23
The Transition From Residency to Fellowship: Enhancing Training by Increasing Transparency	23
Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical Examination	23
Concordance between ultrasound and physical examination in enthesitis assessment: a call for further investigation: comment on the article by Di Matteo et al	23
Systemic autoimmune rheumatic disease risk is associated with long‐term exposure to fine particulate matter: comment on the article by Geslin et al	23
Reply	23
Cartilage Acidic Protein 1 in Plasma Associates With Prevalent Osteoarthritis and Predicts Future Risk as Well as Progression to Joint Replacements: Results From the UK Biobank Resource	23
Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First‐Line Therapy	23
Journal Club	23
Journal Club	23
Reply	23
Genome‐Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim‐Chester Disease	23
Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease	22
Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort	22
Do We Need More Exercise and Osteoarthritis Randomized Clinical Trials?	22
The oral microbiota in persons at risk for rheumatoid arthritis: follow‐up data for the article by Kroese et al	22
How do interleukin‐33 and neutrophil extracellular traps cooperate to induce epithelial‐mesenchymal transition in alveolar epithelial cells?: comment on the article by Yang et al	22
Reply	22
Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis–Associated Interstitial Lung Disease	22
Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c + Dendritic Cell Dysregul	22
Correspondence and comments on American College of Rheumatology and EULAR antiphospholipid syndrome classification criteria: comment on the article by Barbhaiya et al	22
Promotion of Joint Degeneration and Chondrocyte Metabolic Dysfunction by Excessive Growth Hormone in Mice	22
Drug‐Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database	22
Effective Performance of the 2022 American College of Rheumatology/ EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody–Associated	22
Complement	22
ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF ‐1 Signaling	21
WITHDRAWAL: Associations and Diagnostic Accuracy of Ultrasound Features in Knee Osteoarthritis: Comment on the Article by Yates KA et al.	21
Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis	21
Differences in IgG Sialylation Distinguish Asymptomatic From Symptomatic Antinuclear Antibody–Positive Individuals	21
Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma	21
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comor	21
Immunologic Profiling Suggests an Association Between Treg Cell Dysfunction and Pain in Knee Osteoarthritis	21
Plasma Proteomic Profiles Predict Individual Future Osteoarthritis Risk	20
Reply	20
Clinical Connections	20
Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities	20
Clinical Connections	20
Mapping and Analysis of Protein and Gene Profile Identification of the Important Role of Transforming Growth Factor Beta in Synovial Invasion in Patients With Pigmented Villonodular Synovitis	20
Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis	20
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response	20
Journal Club	20
Clinical Connections	20
Weighing the Cardiovascular Risks of Low‐Dose Glucocorticoids in Rheumatoid Arthritis From Real‐World Data	20
Skeletal Muscle Composition, Power, and Mitochondrial Energetics in Older Men and Women With Knee Osteoarthritis	20
Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US	20
Risk of serious infection between belimumab and oral immunosuppressants for non‐renal systemic lupus erythematosus: comment on the article by Materne et al	20
Association of alcohol consumption with disease activity and health‐related quality of life in rheumatoid arthritis: comment on the article by Alfredsson et al	20
	20
Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti‐Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout	19
Issue Information	19
Reply	19
Autoantibodies to Joint‐Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals	19
The effect of air pollution and genetic susceptibility on systemic lupus erythematosus: comment on the article by Xing et al	19
In This Issue	19
Expert Perspective: Hematologic Malignancies and Vasculitis	19
Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al	19
Clinical Images: Erdheim‐Chester disease presenting with palpitations and spondylopathy	19
Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta‐Analyses	19
A Novel Human Interleukin‐23A Overexpressing Mouse Model of Systemic Lupus Erythematosus	18
Long‐Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase III Trial	18
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort	18
Refining the interpretation of drug survival and safety in VEXAS syndrome: the importance of competing risks and exposure time. Comment on the article by Eviatar et al	18
ChatGPT, et al…Artificial Intelligence, Authorship, and Medical Publishing	18
Genetics of Childhood‐Onset Systemic Lupus Erythematosus	18
Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides	18
Diversity and Epitope Spreading of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement	18
Should Low Serum Urate Be Exonerated? Untangling the Influence of Sarcopenia in Observational Studies	18
Serious Infections in Offspring Exposed to Tumor Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability	18
Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis	17
Phenotype Risk Score but Not Genetic Risk Score Aids in Identifying Individuals With Systemic Lupus Erythematosus in the Electronic Health Record	17
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis	17
The Characteristics of Patients With COVID‐19–Associated Pediatric Vasculitis: An International, Multicenter Study	17
Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial	17
Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included	17
Impaired Efferocytosis by Synovial Macrophages in Patients With Knee Osteoarthritis	17
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data	17
An Immunosenescent CD8 + T Cell Subset in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Links Spontaneous Motility to Telomere Shorte	17
Multimodal Single‐Cell Sequencing of B Cells in Primary Sjögren's Syndrome	17